Healthy Clinical Trial
Official title:
The Effect of Supplementation of Vitamin D3 on Inflammation Induced by 100 km Running, Iron Metabolism and Erythropoiesis
Verified date | November 2022 |
Source | Gdansk University of Physical Education and Sport |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A group of runners received vitamin D (10,000 IU - international unit per day) for two weeks. The aim of the intervention was to check the effect of vitamin D supplementation on selected parameters of inflammation and iron metabolism in comparison with the placebo group. Blood was collected before and after supplementation. Next: before, after 25, 50, 75,100 km running and 12 hours after the run. The data were subjected to statistical analysis.
Status | Completed |
Enrollment | 40 |
Est. completion date | December 31, 2022 |
Est. primary completion date | November 1, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 28 Years to 64 Years |
Eligibility | Inclusion Criteria: - male - athletes running ultra-marathons Exclusion Criteria: - vitamin D3 supplementation - multivitamin and iron supplementation - serum 25(OH)D low < 10 ng/mL - serum 25(OH)D high > 100 ng/mL - haemoglobin < 10 g/dL - other (sports injury, tournament) |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Gdansk University of Physical Education and Sport |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The change in vitamin 25(OH)D level after two-week supplementation. | Measured parameter: vitamin 25(OH)D [ng/ml]. | Day 0 to day 14 | |
Primary | The change in parathyroid hormone level after two-week supplementation. | Measured parameter: parathyroid hormone [pg/ml]. | Day 0 to day 14 | |
Primary | Observation of changes in inflammatory parameters:interleukin-6 induced by a 100 km run | Measured parameter of inflammatory: interleukin-6 [pg/ml]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016). | Day "15 - the run" and day "16 - 12 hours after the run" | |
Primary | Observation of changes in inflammatory parameters: C reactive protein - CRP induced by 100 km running. | Measured parameter of inflammatory: CRP[mg/l]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016). | Day "15 - the run" and day "16 - 12 hours after the run" | |
Primary | Observation of changes in creatine kinase level induced by 100 km running. | Measured parameter: creatine kinase [U/l]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016). | Day "15 - the run" and day "16 - 12 hours after the run" | |
Primary | Observation of changes in leucocytes induced by 100 km running. | Measured parameters of inflammatory: leukocytes [G/l]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016). | Day "15 - the run" and day "16 - 12 hours after the run" | |
Secondary | Observation of changes in hepcidin level induced by 100 km running. | Measured parameters of iron metabolism: hepcidin [ng/mL]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016). | Day "15 - the run" and day "16 - 12 hours after the run" | |
Secondary | Observation of changes in serum iron level induced by 100 km running. | Measured serum iron level [µg/dL].Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016). | Day "15 - the run" and day "16 - 12 hours after the run" | |
Secondary | Observation of changes in ferritin induced by 100 km running. | Measured parameters of iron metabolism: ferritin [ng/mL]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12h after the run (06 11 2016). | Day "15 - the run" and day "16 - 12 hours after the run" | |
Secondary | Observation of changes in erythrocytes level induced by a 100 km run. | Measured erythrocytes level [T/l].Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016). | Day "15 - the run" and day "16 - 12 hours after the run" | |
Secondary | Observation of changes in reticulocytes induced by a 100 km run. | Measured reticulocytes [promil]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016). | Day "15 - the run" and day "16 - 12 hours after the run" | |
Secondary | Observation of changes in hematocrit induced by a 100 km run. | Measured hematocrit [%].Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016). | Day "15 - the run" and day "16 - 12 hours after the run" | |
Secondary | Observation of changes in erythropoietin level induced by a 100 km run. | Measured erythropoietin level [mIU - milli-International unit/mL]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016). | Day "15 - the run" and day "16 - 12 hours after the run" | |
Secondary | Observation of changes in erythroferrone level induced by a 100 km run. | Measured erythroferrone level [pg/ml]. Collected blood samples before and after 25, 50, 75 and 100-km run (05 11 2016) and 12 hours after the run (06 11 2016). | Day "15 - the run" and day "16 - 12 hours after the run" |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |